Skip to main content
Book Chapter

Methamphetamine-Associated Psychosis: A Model for Biomarker Discovery in Schizophrenia

  • Bousman C
  • Glatt S
  • Everall I
  • et al.
Springer Netherlands, (2011), 327-343
DOI: 10.1007/978-94-007-0837-2_15
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Methamphetamine-associated psychosis (MAP) has been considered a pharmacological or environmental pathogen model of schizophrenia (SCZ) due in part to similarities in clinical presentation (i.e. paranoia, hallucinations, disorganized speech, and negative symptoms),...

Cite

CITATION STYLE

APA

Bousman, C. A., Glatt, S. J., Everall, I. P., & Tsuang, M. T. (2011). Methamphetamine-Associated Psychosis: A Model for Biomarker Discovery in Schizophrenia. In Handbook of Schizophrenia Spectrum Disorders, Volume I (pp. 327–343). Springer Netherlands. https://doi.org/10.1007/978-94-007-0837-2_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free